Literature DB >> 3278695

Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation.

P Emery1, A F Lopez, G F Burns, M A Vadas.   

Abstract

The level of expression of surface antigens was studied on neutrophils from paired samples of blood and synovial fluid of patients with rheumatoid arthritis (RA). By measuring the immunofluorescence of labelled monoclonal antibodies it was shown that on joint neutrophils there was an increase in expression of complement receptor 3 (CR3) and granulocyte functional antigens 1 and 2 compared with blood neutrophils, whereas the expression of GpIIb-IIIa was reduced. The pattern of expression was the same as that seen with in vitro activation and strongly suggest that activation is occurring within the joint.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278695      PMCID: PMC1003440          DOI: 10.1136/ard.47.1.34

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

2.  Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.

Authors:  S D Wright; P E Rao; W C Van Voorhis; L S Craigmyle; K Iida; M A Talle; E F Westberg; G Goldstein; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 3.  Neutrophils: release of mediators of inflammation with special reference to rheumatoid arthritis.

Authors:  G Weissmann; C Serhan; H M Korchak; J E Smolen
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.

Authors:  D T Fearon; L A Collins
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

5.  Metabolic and secretory properties of peripheral and synovial granulocytes in rheumatoid arthritis.

Authors:  R J van de Stadt; E van de Voorde-Vissers; T M Feltkamp-Vroom
Journal:  Arthritis Rheum       Date:  1980-01

6.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

Authors:  A F Lopez; D J Williamson; J R Gamble; C G Begley; J M Harlan; S J Klebanoff; A Waltersdorph; G Wong; S C Clark; M A Vadas
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

7.  Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.

Authors:  D H Goddard; A P Kirk; J R Kirwan; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

8.  Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis.

Authors:  J Lee; R M Hakim; D T Fearon
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

9.  Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence.

Authors:  D C Anderson; F C Schmalstieg; M A Arnaout; S Kohl; M F Tosi; N Dana; G J Buffone; B J Hughes; B R Brinkley; W D Dickey
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

View more
  16 in total

1.  Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

Authors:  J A Quayle; F Watson; R C Bucknall; S W Edwards
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

3.  Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis.

Authors:  T Felzmann; S Gadd; O Majdic; D Maurer; P Petera; J Smolen; W Knapp
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

4.  Leucocyte integrin and CR1 expression on peripheral blood leucocytes of patients with rheumatoid arthritis.

Authors:  D McCarthy; M J Taylor; J Bernhagen; J D Perry; A S Hamblin
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

5.  Neutrophil function in pregnancy and rheumatoid arthritis.

Authors:  I P Crocker; P N Baker; J Fletcher
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

6.  Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

7.  Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis.

Authors:  F Watson; J J Robinson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

8.  Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis.

Authors:  J J Robinson; F Watson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

9.  Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells.

Authors:  J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

10.  Specific human granulocyte-macrophage colony-stimulating factor antagonists.

Authors:  T R Hercus; C J Bagley; B Cambareri; M Dottore; J M Woodcock; M A Vadas; M F Shannon; A F Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.